SOLANA BEACH, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Bridgetech Holdings International, Inc. (OTCPK: BGTH), a company focused on maximizing the potential of emerging healthcare products and services in China and the U.S., today announced that they executed a strategic partnership agreement with MCC Global to share knowledge and products. MCC Global was an investor in the recently announced $3 million restricted stock private placement.
"We are very pleased to join forces with MCC," said Michael Chermak, President and CEO of Bridgetech. "They are pursuing similar strategies but are in markets that Bridgetech is not focused on. This relationship adds attractive products to our China pipeline and allows us to leverage our existing products in other markets without taking our eye off the ball."
"MCC has a wealth of high level access and industry experience. That, coupled with the quality of their additional service offerings will be extremely valuable to Bridgetech," continued Mr. Chermak. "We feel that the cross pollination will exponentially increase the value of both of our portfolio's."
"We have assembled a wide array of complementary entities, dedicated to supporting our strategy," said Tony Moore, CEO of Moore, Clayton and Company. "Bridgetech can leverage these entities and our lessons learned to support their efforts in a timely and cost effective manner. No need for them to recreate the wheel. Obviously we think Bridgetech's strategy is on point and what we bring to the table for them in terms of products, services and access makes them an extremely attractive investment."
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western Healthcare in China. The Company is bringing emerging drugs, devices and diagnostics to China, with an initial focus on Oncology and Women's Health. In addition to the China healthcare market, Bridgetech is focusing on the areas of medical imaging and non-invasive surgery, nurse recruitment and training, and RFID based hospital asset management. For additional information, please visit http://www.bthi.com .
About Moore, Clayton & Company
MCC provides strategic and financial advisory, operating and investment solutions to early, mid and late stage companies thereby leveraging their global expertise, vertical market experience and extensive senior level international network. Tony Moore and Sharon Clayton, MCC co-Chairmen & co-CEO's, founded MCC in 1999. Mr. Moore's tenure as Managing Director of Goldman Sachs Asia in Hong Kong provides additional insight and access to their business partners. For additional information, please visit http://www.mccglobal.com .
Forward-Looking Statements.
Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.
Investor Relations: Redwood Consultants, LLC 415-884-0348 Approved by: Bridgetech Holdings International, Inc. Thomas C. Kuhn III 678-428-3507
Bridgetech Holdings International, Inc.CONTACT: Investor Relations: Redwood Consultants, LLC, +1-415-884-0348,for Bridgetech Holdings International, Inc.; or Thomas C. Kuhn III ofBridgetech Holdings International, Inc., +1-678-428-3507
